Connor, Clark & Lunn Investment Management (CC&L)’s Adverum Biotechnologies ADVM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,261
Closed -$85.3K 1387
2024
Q4
$85.3K Buy
18,261
+5,057
+38% +$23.6K ﹤0.01% 1365
2024
Q3
$92.7K Buy
+13,204
New +$92.7K ﹤0.01% 1373
2023
Q3
Sell
-8,428
Closed -$134K 1340
2023
Q2
$134K Sell
8,428
-6,558
-44% -$104K ﹤0.01% 1231
2023
Q1
$108K Sell
14,986
-5,063
-25% -$36.3K ﹤0.01% 1147
2022
Q4
$116K Sell
20,049
-324
-2% -$1.88K ﹤0.01% 1099
2022
Q3
$194K Buy
20,373
+8,622
+73% +$82.1K ﹤0.01% 997
2022
Q2
$141K Sell
11,751
-18,521
-61% -$222K ﹤0.01% 963
2022
Q1
$397K Sell
30,272
-3,602
-11% -$47.2K ﹤0.01% 823
2021
Q4
$596K Sell
33,874
-2,967
-8% -$52.2K ﹤0.01% 769
2021
Q3
$799K Buy
+36,841
New +$799K ﹤0.01% 682
2019
Q2
Sell
-7,203
Closed -$377K 975
2019
Q1
$377K Sell
7,203
-1,630
-18% -$85.3K ﹤0.01% 714
2018
Q4
$278K Sell
8,833
-6,832
-44% -$215K ﹤0.01% 799
2018
Q3
$948K Sell
15,665
-500
-3% -$30.3K 0.01% 574
2018
Q2
$857K Sell
16,165
-1,010
-6% -$53.5K ﹤0.01% 644
2018
Q1
$996K Sell
17,175
-2,380
-12% -$138K 0.01% 484
2017
Q4
$684K Sell
19,555
-3,320
-15% -$116K ﹤0.01% 573
2017
Q3
$835K Sell
22,875
-60
-0.3% -$2.19K 0.01% 556
2017
Q2
$573K Hold
22,935
﹤0.01% 579
2017
Q1
$619K Sell
22,935
-100
-0.4% -$2.7K ﹤0.01% 588
2016
Q4
$668K Sell
23,035
-3,190
-12% -$92.5K ﹤0.01% 551
2016
Q3
$1.08M Sell
26,225
-4,020
-13% -$165K 0.01% 460
2016
Q2
$956K Sell
30,245
-980
-3% -$31K 0.01% 473
2016
Q1
$1.61M Buy
31,225
+390
+1% +$20.2K 0.01% 367
2015
Q4
$2.94M Buy
30,835
+10,875
+54% +$1.04M 0.02% 279
2015
Q3
$1.65M Buy
19,960
+18,160
+1,009% +$1.5M 0.01% 324
2015
Q2
$292K Buy
+1,800
New +$292K ﹤0.01% 500